Topics | Cellgenetherapyreview.com

AAV characterization: current status and future advances
Wednesday, November 20, 2024
For the successful delivery of functional genes to patients, recombinant adenoviral-associated vectors (AAVs) are the most established and leading platform for rare and severe human diseases. read more
How preservation equipment can mitigate risk in CGT research
Wednesday, November 06, 2024
The limitations of current preservation approaches are driving researchers toward new alternatives read more
Maintaining contamination control in advanced therapy manufacturing
Wednesday, November 06, 2024
Facilities that make cell and gene therapies require cleaning and disinfection strategies not found at other drug manufacturing sites read more
Will the future include CAR-T-similars?
Thursday, October 31, 2024
Evaluating the factors that would support or preclude the birth and expansion of biosimilar versions of CAR-T therapies read more
Adding real-time analytics to automated cell therapy manufacturing
Wednesday, October 30, 2024
The synergy between automated cell expansion systems and real-time analyzers creates a powerful combination for monitoring cell expansion processes read more